Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1975 Dec;55(4):555–557. doi: 10.1111/j.1476-5381.1975.tb07432.x

The actions of flupenthixol upon 5-hydroxytryptamine-induced aggregation and the uptake of 5-hydroxytryptamine and dopamine by human blood platelets.

D J Boullin, R P Grimes, M W Orr
PMCID: PMC1666734  PMID: 2360

Abstract

The effects of the alpha- and beta-isomers of flupenthixol on 5-hydroxytryptamine (5-HT)-induced platelet aggregation and on 5-HT and dopamine uptake were investigated. Alpha-Flupenthixol was 185 times more potent than the beta-isomer as an inhibitor of platelet aggregation. In contrast both isomers were equipotent as inhibitors of uptake of 5-HT and dopamine. The data suggest that 5-HT-induced aggregation and uptake are separate processes.

Full text

PDF
555

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Born G. V., Juengjaroen K., Michal F. Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues. Br J Pharmacol. 1972 Jan;44(1):117–139. doi: 10.1111/j.1476-5381.1972.tb07244.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boullin D. J., Grahame-Smith D. G., Grimes R. P., Woods H. F. Inhibition of 5-hydroxytryptamine-induced human blood platelet aggregation by chlorpromazine and its metabolites. Br J Pharmacol. 1975 Jan;53(1):121–125. doi: 10.1111/j.1476-5381.1975.tb07338.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boullin D. J., Green A. R., Price K. S. The mechanism of adenosine diphosphate induced platelet aggregation: binding to platelet receptors and inhibition of binding and aggregation by prostaglandin E 1 . J Physiol. 1972 Mar;221(2):415–426. doi: 10.1113/jphysiol.1972.sp009758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boullin D. J., O'Brien R. A. Accumulation of dopamine by blood platelets from normal subjects and parkinsonian patients under treatment with L-DOPA. Br J Pharmacol. 1970 Aug;39(4):779–788. doi: 10.1111/j.1476-5381.1970.tb09904.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boullin D. J., Woods H. F., Grimes R. P., Grahame-Smith D. G. Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine. Br J Clin Pharmacol. 1975 Feb;2(1):29–35. doi: 10.1111/j.1365-2125.1975.tb00468.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Nielsen I. M., Pedersen V., Nymark M., Franck K. F., Boeck V., Fjalland B., Christensen A. V. The comparative pharmacology of flupenthixol and some reference neuroleptics. Acta Pharmacol Toxicol (Copenh) 1973;33(5):353–362. doi: 10.1111/j.1600-0773.1973.tb01537.x. [DOI] [PubMed] [Google Scholar]
  7. Reiter P. J. On flupentixol, an antidepressant of a new chemical group. Br J Psychiatry. 1969 Dec;115(529):1399–1402. doi: 10.1192/bjp.115.529.1399. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES